keyboard_arrow_up

Global Lymphangioleiomyomatosis Clinical Trials Market Review H2 2014

“Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2014″ provides data on the Lymphangioleiomyomatosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lymphangioleiomyomatosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lymphangioleiomyomatosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=249963 .

This is a premium report priced at US$2500 for a single user PDF.

List of Tables

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials by Region, 2014* 7

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Lymphangioleiomyomatosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13

Proportion of Lymphangioleiomyomatosis to Respiratory Clinical Trials, G7 Countries (%), 2014* 14

Lymphangioleiomyomatosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15

Lymphangioleiomyomatosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16

Proportion of Lymphangioleiomyomatosis to Respiratory Clinical Trials, E7 Countries (%), 2014* 17

Lymphangioleiomyomatosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials by Phase, 2014* 19

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20

Lymphangioleiomyomatosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23

Lymphangioleiomyomatosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25

Lymphangioleiomyomatosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 27

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 28

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014* 29

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Russian Academy of Medical Sciences, 2014* 30

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by International Medical Center of Japan, 2014* 31

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2014* 32

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2014* 33

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 34

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 35

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 36

Lymphangioleiomyomatosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 37

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies